m+Medelevator.RU
← Поиск публикаций
Ophthalmology · 2010

Short-term visual outcomes of Boston type 1 keratoprosthesis implantation.

СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Dunlap Karen, Chak Garrick, Aquavella James V, Myrowitz Elliott, Utine Canan Asli, Akpek Esen

Аннотация

PURPOSE: To report the short-term visual outcomes after keratoprosthesis implantation.

DESIGN: Retrospective multi center case series (Wilmer Eye Institute and University of Rochester Eye Institute).

PARTICIPANTS: One hundred twenty-two patients (126 eyes) with corneal diseases that were deemed ineligible to receive donor corneal transplants.

INTERVENTION: Patients underwent a Boston type I keratoprosthesis procedure for visual rehabilitation.

MAIN OUTCOME MEASURES: The medical records of the patients were reviewed to assess intraoperative and postoperative complications, uncorrected and best-corrected visual acuity, as well as the degree of refractive error at various time points.

RESULTS: One hundred four patients (82.5%) achieved improved vision within 6 months after surgery. An overwhelming majority of those patients who had improved vision had a manifest refraction of plano. The mean spherical refractive error was -0.57 diopters (D) and mean astigmatism was 0.10 D. Cumulatively, 7.1% patients achieved their best-corrected vision at 1 day, 24.6% at 1 week, and 70.6% at 3 months. The patients who achieved their best-corrected visual acuity after the first 3-month period most often were the ones who required multiple surgeries owing to preexisting or postoperative complications.

CONCLUSIONS: Boston keratoprosthesis seems to provide rapid visual recovery with excellent uncorrected acuity in the early postoperative period.

FINANCIAL DISCLOSURE(S): The authors have no proprietary or commercial interest in any of the materials discussed in this article.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты